Noncanonical retinoic acid signaling

Area of Science:

• Molecular Biology
• Cell Signaling
• Vitamin A Metabolism

Background:

• All-trans retinoic acid (atRA), a Vitamin A metabolite, classically regulates gene expression via nuclear retinoic acid receptors (RARs).
• Emerging evidence highlights noncanonical activities of atRA, independent of RARs, suggesting alternative mechanisms of action.
• Cellular retinoic acid binding protein 1 (CRABP1) has been implicated in mediating these novel functions.

Purpose of the Study:

• To identify the primary mediator of noncanonical all-trans retinoic acid (atRA) activities.
• To elucidate the molecular mechanisms by which CRABP1 mediates noncanonical atRA functions.
• To describe experimental systems for studying CRABP1-dependent noncanonical atRA activities.

Main Methods:

• In vivo and in vitro experimental systems.
• Biochemical assays to detect protein-ligand interactions.
• Cellular signaling pathway analysis (e.g., MAPK, CaMKII).

Main Results:

• Cellular retinoic acid binding protein 1 (CRABP1) identified as the primary mediator of noncanonical atRA activities.
• atRA binding to CRABP1 facilitates rapid formation of signaling scaffolds.
• CRABP1-atRA complex dampens MAPK activation in stem cells and reduces CaMKII activity in cardiomyocytes.

Conclusions:

• CRABP1 is a key mediator of noncanonical atRA signaling, acting independently of RARs.
• CRABP1-atRA interactions rapidly modulate cell context-specific signaling pathways.
• This mechanism provides novel insights into the diverse biological roles of Vitamin A metabolites.